本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Abeona Therapeutics Inc

5.47
+0.04000.74%
盤後5.46-0.0100-0.18%19:30 EDT
成交量:193.48萬
成交額:1,046.85萬
市值:3.12億
市盈率:-4.88
高:5.56
開:5.42
低:5.32
收:5.43
52周最高:7.65
52周最低:4.00
股本:5,704.90萬
流通股本:3,691.95萬
量比:1.22
換手率:5.24%
股息:- -
股息率:- -
每股收益(TTM):-1.1200
每股收益(LYR):1.01
淨資產收益率:-43.13%
總資產收益率:-24.55%
市淨率:2.44
市盈率(LYR):5.42

資料載入中...

2026/06/04

重要事件披露

Form 8-K - Current report
2026/05/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/13

重要事件披露

Form 8-K - Current report
2026/05/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/29

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/07

重要事件披露

Form 8-K - Current report
2026/04/06

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/03/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/20

重要事件披露

Form 8-K - Current report
2026/03/17

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/17

重要事件披露

Form 8-K - Current report
2026/03/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/09

重要事件披露

Form 8-K - Current report
2026/02/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities